Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Halozyme Therapeutic (NQ: HALO )

51.53 +0.41 (+0.81%)
Streaming Delayed Price Updated: 3:45 PM EST, Jan 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 427,287
Open 51.36
Bid (Size) 51.53 (1)
Ask (Size) 51.55 (1)
Prev. Close 51.12
Today's Range 51.17 - 52.15
52wk Range 32.00 - 59.46
Shares Outstanding 142,334,900
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Sharp Tesla price cuts and some notable earnings were in focus. 
Via Investor's Business Daily
Nasdaq Rises Over 1%; CommVault Systems Shares Plummet
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Wednesday. 
Via Benzinga

Performance

YTD
-6.52%
-6.52%
1 Month
-6.52%
-6.52%
3 Month
+7.79%
+7.79%
6 Month
+6.19%
+6.19%
1 Year
+48.90%
+48.90%

More News

Read More
CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Where Halozyme Therapeutics Stands With Analysts
Via Benzinga
5 Analysts Have This to Say About Halozyme Therapeutics
Via Benzinga
4 Analysts Have This to Say About Halozyme Therapeutics
Via Benzinga
Halozyme Therapeutics Shares Jump On Better Than Expected Annual Guidance
Via Benzinga
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
US Stocks Open Higher; Nasdaq Rises 60 Points
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
Via Benzinga
Argenx's Flagship Neuromuscular Treatment For Subcutaneous Injection Goes Under Priority FDA Review
Via Benzinga
Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina
Via Benzinga
Stock Market Rally Roars Higher On Cooling Inflation; Bitcoin, Meta, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Argenx Seeks FDA Nod For Its Flagship Neuromuscular Treatment Formulated For Subcutaneous Injection
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Halozyme Therapeutics: Q2 Earnings Insights
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
Via Benzinga
7 Biotech Stocks With Key Catalysts Coming in July
Via InvestorPlace
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.